BarnaM., UomoI., & PastorelloM. (2013). Oral Agents for Treatment of Patients with Advanced Pancreatic Neuroendocrine Tumors: Could Pharmaeconomic, Cost-Effectiveness Data Play a Significant Role?. JOP. Journal of the Pancreas, 14(1), 102-104. https://doi.org/10.6092/1590-8577/1354